undamentalytics Newsletter
Sign in

Alignment Healthcare, Inc. income statement

In fiscal 2025, Alignment Healthcare, Inc. reported revenue of $3.95bn, up 46.1% on the year before, operating income of $14.8m (a 0.4% margin) and net income of −$724,000, or $0.00 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue7579591,1681,4341,8242,7043,9494,942
Selling, general and administrative110156291296307371443514
Operating income−29−5−178−129−128−1021544
Interest expense1517171821241617
Income before tax−45−23−195−149−148−128−127
Income tax0000−000−2
Net income−45−23−195−150−148−128−129
Diluted EPS−$0.03−$0.01−$1.14−$0.83−$0.79−$0.67$0.00$0.14
Diluted shares (average)——182m181m186m191m198m204m
EBITDA−1510−162−111−106−754575

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ALHC vs CLOVALHC vs OSCRALHC vs MOH

More: Managed Health Care stocks compared, Health Care sector, rankings of US companies

Figures from Alignment Healthcare, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Alignment Healthcare, Inc.